PAVmed (PAVM) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $2.42, +5.90% vs the prior close of $2.29.
- Volume 8.40K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PAVM jumps 5.9% to $2.42. Closed at $2.42, +5.90% vs the prior close of $2.29. Day range $2.22–$2.51, opened at $2.22.
PAVM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — PAVM jumps 5.9% to $2.42
- Closed at $2.42, +5.90% vs the prior close of $2.29. Day range $2.22–$2.51, opened at $2.22.
- Volume was 8.40K shares, 0.2x its 50-day average of 35.23K — lighter than usual.
- Price is -42.0% vs its 50-day average ($4.18) and -64.7% vs its 200-day average ($6.87).
- 52-week range $2.22–$28.44; today's close sits at 1% of that range, 91.5% below the 52-week high.
Oct 14, 2026 — PAVM slides 13.3% to $2.29, a 52-week low, 3 down days in a row
- Closed at $2.29, -13.26% vs the prior close of $2.64. Day range $2.27–$2.60, opened at $2.53.
- Volume was 6.40K shares, 0.2x its 50-day average of 35.31K — lighter than usual.
- Price is -45.9% vs its 50-day average ($4.23) and -66.8% vs its 200-day average ($6.90).
- 52-week range $2.27–$28.44; today's close sits at 0% of that range, 91.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — PAVM dips 1.9% to $2.64, a 52-week low
- Closed at $2.64, -1.86% vs the prior close of $2.69. Day range $2.58–$2.81, opened at $2.61.
- Volume was 3.20K shares, 0.1x its 50-day average of 35.39K — lighter than usual.
- Price is -38.4% vs its 50-day average ($4.29) and -61.9% vs its 200-day average ($6.93).
- 52-week range $2.58–$28.44; today's close sits at 0% of that range, 90.7% below the 52-week high.
Oct 12, 2026 — PAVM slides 3.6% to $2.69
- Closed at $2.69, -3.58% vs the prior close of $2.79. Day range $2.69–$2.80, opened at $2.70.
- Volume was 8.60K shares, 0.2x its 50-day average of 35.30K — lighter than usual.
- Price is -38.1% vs its 50-day average ($4.34) and -61.3% vs its 200-day average ($6.96).
- 52-week range $2.58–$28.44; today's close sits at 0% of that range, 90.5% below the 52-week high.
Oct 9, 2026 — PAVM jumps 3.7% to $2.79
- Closed at $2.79, +3.72% vs the prior close of $2.69. Day range $2.58–$2.89, opened at $2.58.
- Volume was 12.20K shares, 0.3x its 50-day average of 35.11K — lighter than usual.
- Price is -36.4% vs its 50-day average ($4.39) and -60.1% vs its 200-day average ($6.99).
- 52-week range $2.58–$28.44; today's close sits at 1% of that range, 90.2% below the 52-week high.
Oct 8, 2026 — PAVM dips 1.8% to $2.69
- Closed at $2.69, -1.82% vs the prior close of $2.74. Day range $2.65–$2.76, opened at $2.76.
- Volume was 3.80K shares, 0.1x its 50-day average of 35.06K — lighter than usual.
- Price is -39.3% vs its 50-day average ($4.43) and -61.7% vs its 200-day average ($7.02).
- 52-week range $2.60–$28.44; today's close sits at 0% of that range, 90.5% below the 52-week high.
Oct 7, 2026 — PAVM rises 2.4% to $2.74
- Closed at $2.74, +2.43% vs the prior close of $2.67. Day range $2.60–$2.84, opened at $2.70.
- Volume was 28.10K shares, 0.8x its 50-day average of 34.57K.
- Price is -38.9% vs its 50-day average ($4.48) and -61.2% vs its 200-day average ($7.05).
- 52-week range $2.60–$28.44; today's close sits at 1% of that range, 90.4% below the 52-week high.
Oct 6, 2026 — PAVM rises 0.6% to $2.67
- Closed at $2.67, +0.56% vs the prior close of $2.66. Day range $2.65–$2.93, opened at $2.65.
- Volume was 15.20K shares, 0.4x its 50-day average of 34.46K — lighter than usual.
- Price is -41.0% vs its 50-day average ($4.53) and -62.2% vs its 200-day average ($7.08).
- 52-week range $2.61–$28.44; today's close sits at 0% of that range, 90.6% below the 52-week high.
Oct 5, 2026 — PAVM slides 7.3% to $2.66, a 52-week low
- Closed at $2.66, -7.32% vs the prior close of $2.87. Day range $2.66–$2.85, opened at $2.81.
- Volume was 7.40K shares, 0.2x its 50-day average of 34.62K — lighter than usual.
- Price is -42.0% vs its 50-day average ($4.58) and -62.6% vs its 200-day average ($7.11).
- 52-week range $2.61–$28.44; today's close sits at 0% of that range, 90.6% below the 52-week high.
Oct 2, 2026 — PAVM jumps 6.3% to $2.87
- Closed at $2.87, +6.30% vs the prior close of $2.70. Day range $2.65–$2.99, opened at $2.69.
- Volume was 28.60K shares, 0.8x its 50-day average of 34.55K.
- Price is -38.0% vs its 50-day average ($4.63) and -59.8% vs its 200-day average ($7.15).
- 52-week range $2.61–$28.44; today's close sits at 1% of that range, 89.9% below the 52-week high.
PAVM latest news & SEC filings
Every SEC filing by or about PAVM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 10, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $33.00K (prior year $6.00K) (+450.0% vs Jun 30, 2025)
- Net income: -$5.38M (prior year -$11.92M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.87 (prior year -$22.08) (loss narrowed vs Jun 30, 2025)
Jul 30, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade PAVM
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 15, 2026, Mar 30, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.64% (largest 26.8%). That is a volatile stock.
- Liquidity: about 21.84K shares (≈$52.96K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.42 vs a range of $2.22–$28.44 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:30 on Jan 2, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 10, 2026; 8-K Aug 14, 2026; 10-Q Aug 13, 2026.
- Share count: 8.00M shares outstanding (Aug 13, 2026), -52.4% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
PAVM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.22 | 2.51 | 2.22 | 2.42 | 8.40K |
| Oct 14, 2026 | 2.53 | 2.60 | 2.27 | 2.29 | 6.40K |
| Oct 13, 2026 | 2.61 | 2.81 | 2.58 | 2.64 | 3.20K |
| Oct 12, 2026 | 2.70 | 2.80 | 2.69 | 2.69 | 8.60K |
| Oct 9, 2026 | 2.58 | 2.89 | 2.58 | 2.79 | 12.20K |
| Oct 8, 2026 | 2.76 | 2.76 | 2.65 | 2.69 | 3.80K |
| Oct 7, 2026 | 2.70 | 2.84 | 2.60 | 2.74 | 28.10K |
| Oct 6, 2026 | 2.65 | 2.93 | 2.65 | 2.67 | 15.20K |
| Oct 5, 2026 | 2.81 | 2.85 | 2.66 | 2.66 | 7.40K |
| Oct 2, 2026 | 2.69 | 2.99 | 2.65 | 2.87 | 28.60K |
| Oct 1, 2026 | 3.61 | 3.69 | 2.61 | 2.70 | 187.70K |
| Sep 30, 2026 | 3.70 | 3.79 | 3.66 | 3.69 | 3.20K |
| Sep 29, 2026 | 3.83 | 4.07 | 3.82 | 3.82 | 5.00K |
| Sep 28, 2026 | 3.78 | 4.13 | 3.78 | 3.80 | 8.60K |
| Sep 25, 2026 | 3.89 | 4.06 | 3.75 | 3.85 | 24.30K |
| Sep 24, 2026 | 4.15 | 4.30 | 3.85 | 3.88 | 10.00K |
| Sep 23, 2026 | 4.07 | 4.14 | 3.99 | 3.99 | 2.70K |
| Sep 22, 2026 | 3.90 | 4.33 | 3.86 | 4.18 | 17.00K |
| Sep 21, 2026 | 3.91 | 4.01 | 3.79 | 3.97 | 33.10K |
| Sep 18, 2026 | 3.97 | 4.29 | 3.88 | 3.96 | 23.30K |
About PAVmed
PAVmed (PAVM) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1624326.
PAVM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Sundeep Agrawal | Director | Apr 3, 2026 |
| Lishan Aklog | Chairman and CEO | Apr 3, 2026 |
| Timothy E Baxter | Director | Apr 3, 2026 |
| Michael J Glennon | Director | Apr 3, 2026 |
| Ronald M Sparks | Director | Apr 3, 2026 |
| Debra White | Director | Apr 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lishan Aklog | Chairman and CEO | Apr 3, 2026 |
| Michael Adam Gordon | General Counsel | Apr 3, 2026 |
| Victoria Tou-Ho Lee | Chief Medical Officer | Apr 13, 2026 |
| Dennis M Mcgrath | President and CFO | Apr 3, 2026 |
| Shaun O'Neil | Chief Operating Officer | Apr 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
PAVM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $71.00K | $401.00K | -5.63 | $-5.21M |
| Dec 31, 2024 | $3.00M | $39.79M | 14.90 | $-33.55M |
| Dec 31, 2023 | $2.45M | $-64.17M | -9.16 | $-52.04M |
| Dec 31, 2022 | $377.00K | $-88.98M | -15.03 | $-70.98M |
| Dec 31, 2021 | $500.00K | $-50.35M | — | $-40.59M |
Latest balance sheet: total assets $40.21M, total liabilities $20.91M, cash $3.78M (as of Jun 30, 2026).
PAVM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $5.20 |
| May 15, 2026 | 8-K Item 2.02 (results) | $6.53 |
| Mar 30, 2026 | 8-K Item 2.02 (results) | $9.80 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $10.62 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $13.68 |
| May 15, 2025 | 8-K Item 2.02 (results) | $18.90 |
| Mar 25, 2025 | 8-K Item 2.02 (results) | $22.80 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $32.70 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Nov 15, 2023 | 8-K Item 2.02 (results) | — |
| Mar 15, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on PAVM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.